Company profile: Precision Neuroscience
1.1 - Company Overview
Company description
- Provider of brain-computer interface technology, including the Layer 7 Cortical Interface, a minimally invasive, high-resolution implant for recording and stimulating brain activity; Precision BioMEMS microfabrication of biocompatible microelectrode arrays and foundry services; machine learning software to translate neural data; and a fast, reversible surgical implantation technique.
Products and services
- Layer 7 Cortical Interface: A brain-computer interface implant architected for minimally invasive surgery, records and stimulates brain activity with high resolution
- Machine Learning Software: A machine-learning system developed to translate neural data into computer code, enabling communication between the brain and digital devices
- Minimally Invasive Surgery Technique: A reversible surgical method to implant the Layer 7 Cortical Interface quickly without damaging brain tissue
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Precision Neuroscience
Remedy Pharmaceuticals
HQ: United States
Website
- Description: Provider of clinical-stage small molecule drug therapies for acute central nervous system disorders, developing treatments that target NCCa-ATP channels in traumatic brain injury, stroke, and spinal cord injury, including RP-1127, an intravenous glyburide inhibitor acting through type-1 sulfonylurea antagonism.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Remedy Pharmaceuticals company profile →
Gabather
HQ: Sweden
Website
- Description: Provider of research and development of innovative therapeutics for neuropsychiatric disorders, focusing on pro-cognitive drug candidates targeting GABAA receptor systems for central nervous system disorders, including GT-002, a small-molecule GABAA receptor PAM in clinical development to improve learning and memory, reduce anxiety, and promote social interaction.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gabather company profile →
ElectroCore
HQ: United States
Website
- Description: Provider of neuromodulation therapies for the non-invasive treatment of diseases and disorders, including gammaCore and gammaCore Sapphire devices offering non-invasive vagus nerve stimulation for migraine and cluster headache treatment; Truvaga, a natural solution designed to enhance mental clarity and overall health; and TAC-STIM, a portable device aimed at the military for vagus nerve stimulation with quick administration and long-lasting benefits.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ElectroCore company profile →
Vico Therapeutics
HQ: The Netherlands
Website
- Description: Provider of RNA-modulating therapies for rare neurological/CNS disorders, focused on SCA, HD and RTT. Offers VO659, an antisense oligonucleotide targeting CAG repeat expansions in polyglutamine diseases (Spinocerebellar Ataxia types 1/3 and Huntington’s) to reduce mutant protein levels and improve motor function, and VICOMER, a platform designing RNA therapeutics via translation, splicing, editing, degradation and activation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vico Therapeutics company profile →
Enterin
HQ: United States
Website
- Description: Provider of biotechnology therapeutics developing oral and subcutaneous compounds: ENT-01 displaces alpha-synuclein aggregates from enteric nerve cells to improve gut-brain signaling, being developed for Parkinson’s Disease and its non-motor symptoms; ENT-03 reverses central insulin resistance to increase insulin sensitivity and normalize blood sugar, being developed for obesity, type 2 diabetes, and Alzheimer’s Disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enterin company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Precision Neuroscience
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Precision Neuroscience
2.2 - Growth funds investing in similar companies to Precision Neuroscience
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Precision Neuroscience
4.2 - Public trading comparable groups for Precision Neuroscience
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →